PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: IS CHEMOTHERAPY NECESSARY?

被引：0
|
作者：
Foa, Robin [1 ]
机构：
[1] Sapienza Univ, Hematol, Dept Biomed Sci & Hematol, Rome, Italy
来源：
LEUKEMIA RESEARCH | 2017年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-10
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [31] Disseminated Geosmithia argillacea Infection in a Patient with Ph-Positive Acute Lymphoblastic Leukemia. Case Report and Literature Review
    Giordano, Antonio
    Di Landro, Francesca
    De Carolis, Elena
    Criscuolo, Marianna
    Dragonetti, Giulia
    Fianchi, Luana
    Pagano, Livio
    JOURNAL OF FUNGI, 2021, 7 (09)
  • [32] PH-POSITIVE LEUKEMIA - A TRANSGENIC MOUSE MODEL
    GROFFEN, J
    VONCKEN, JW
    KAARTINEN, V
    MORRIS, C
    HEISTERKAMP, N
    LEUKEMIA & LYMPHOMA, 1993, 11 : 19 - 24
  • [33] Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemia
    Marchesi, Francesco
    Salvatorelli, Emanuela
    Renzi, Daniela
    Mengarelli, Andrea
    Minotti, Giorgio
    Menna, Pierantonio
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : E15 - +
  • [34] NEAR-TRIPLOID PH-POSITIVE LEUKEMIA
    OHTAKI, K
    ABE, R
    TEBBI, CK
    DELOSSANTOS, R
    HAN, T
    SANDBERG, AA
    CANCER GENETICS AND CYTOGENETICS, 1985, 18 (02) : 113 - 121
  • [35] Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia
    Gazeau, Nicolas
    Derrieux, Coralie
    Nibourel, Olivier
    Berthon, Celine
    Grardel, Nathalie
    Goursaud, Laure
    Boyer, Thomas
    Dumezy, Florent
    Coiteux, Valerie
    Quesnel, Bruno
    Preudhomme, Claude
    Roche-Lestienne, Catherine
    Duployez, Nicolas
    LEUKEMIA, 2020, 34 (08) : 2230 - 2233
  • [36] The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells
    Kuwatsuka, Y.
    Minami, M.
    Minami, Y.
    Sugimoto, K.
    Hayakawa, F.
    Miyata, Y.
    Abe, A.
    Goff, D. J.
    Kiyoi, H.
    Naoe, T.
    BLOOD CANCER JOURNAL, 2011, 1 : e17 - e17
  • [37] A Propensity Score Weighting Analysis Emphasizes the Progress of the Gimema Approach in Adult Ph-Positive Acute Lymphoblastic Leukemia in the TKI Era
    Piciocchi, Alfonso
    Chiaretti, Sabina
    Cipriani, Marta
    Messina, Monica
    Elia, Loredana
    Della Starza, Irene
    Vitale, Antonella
    Fazi, Paola
    Vignetti, Marco
    Foa, Robin
    BLOOD, 2023, 142
  • [38] Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia
    Nicolas Gazeau
    Coralie Derrieux
    Olivier Nibourel
    Céline Berthon
    Nathalie Grardel
    Laure Goursaud
    Thomas Boyer
    Florent Dumezy
    Valérie Coiteux
    Bruno Quesnel
    Claude Preudhomme
    Catherine Roche-Lestienne
    Nicolas Duployez
    Leukemia, 2020, 34 : 2230 - 2233
  • [39] The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells
    Y Kuwatsuka
    M Minami
    Y Minami
    K Sugimoto
    F Hayakawa
    Y Miyata
    A Abe
    D J Goff
    H Kiyoi
    T Naoe
    Blood Cancer Journal, 2011, 1 : e17 - e17
  • [40] THE FREQUENCY AND PROGNOSTIC SIGNIFICANCE OF IKZF1 DELETIONS IN ADULT PH-POSITIVE AND PH-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED IN RUSSIAN ACUTE LYMPHOBLASTIC LEUKEMIA STUDIES.
    Baskhaeva, G.
    Biderman, B.
    Gavrilina, O.
    Zarubina, K.
    Lukyanova, I.
    Stepanova, E.
    Troitskaya, V.
    Sudarikov, A.
    Parovichnikova, E.
    HAEMATOLOGICA, 2017, 102 : 662 - 663
12345